Forest City Ratner Cos. announced Jan. 23 that Two Sigma Investments, a tech and investment firm, is the first company to be selected to locate at The Bridge at Cornell Tech.
A gene essential for making blood vessels in embryos can successfully transform amniotic cells into therapeutic blood vessel cells, according to new research from Weill Cornell Medicine.
The incidence of metastatic prostate cancer in older men is rising after reaching an all-time low in 2011. The findings suggest a correlation between the increase and a change in prostate cancer screening guidelines recommending against routine PSA testing.
Scientists from Weill Cornell Medicine discovered an internal code in cellular molecules, called messenger RNA, predetermines how much protein they will produce.
A simple blood test may better predict which patients diagnosed with liver cancer will experience disease reoccurrence, according to new research from Weill Cornell Medicine scientists.
Professor and chair of city and regional planning Susan Christopherson, known for her scholarly work and expertise on regional economic development, died Dec. 14, 2016, following a battle with cancer. She was 69.
Dr. Michael Satlin at Weill Cornell Medicine and Ilana Brito in Ithaca are researching how to fight drug-resistant bacteria – "superbugs" that threaten cancer patients' fragile immune systems.
